EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease
EnClear Therapies has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in September 2024.
EnClear Therapies's investors include Founders Fund, Presight Capital, Tachyon Ventures, Thiel Capital, Amgen Ventures.
EnClear Therapies is headquartered in Cambridge, United States.
EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease
EnClear Therapies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EnClear Therapies — Funding & Investors." VCBacked, September 3, 2024, https://www.vcbacked.co/company/enclear-therapies. Accessed November 13, 2026.
VCBacked. (2024). EnClear Therapies — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/enclear-therapies
{{cite web |title=EnClear Therapies — Funding & Investors |url=https://www.vcbacked.co/company/enclear-therapies |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at EnClear Therapies? Request a listing update